<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02695706</url>
  </required_header>
  <id_info>
    <org_study_id>LM Farma</org_study_id>
    <nct_id>NCT02695706</nct_id>
  </id_info>
  <brief_title>Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use</brief_title>
  <official_title>Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use and Evaluation of the Effectiveness Through the Self Awareness of the Research, of Clinical Evaluations and Instrumental Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LM Farma Indústria e Comércio Ltda.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LM Farma Indústria e Comércio Ltda.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The measured product in this research is a product for topical use, Laboratoires
      Mercurochrome Reparador e Protetor. The expected benefit to the use of the product is the
      improvement in skin hydration as measured by self perception of participant research and
      clinical evaluation and improvement in local microcirculation, assessed by instrumental
      measurements in feet of the study participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study is to verify the skin acceptability through the non-occurrence
      of adverse events and cutaneous sensations of discomfort, evaluate the moisturizing efficacy
      of the product through self perception of research participants and dermatological clinical
      evaluation to assess the improvement in local microcirculation by performing of instrumental
      measurements in the feet of diabetic participants, product Laboratoires Mercurochrome
      Repairer and Protector referred by LM FARMA INDUSTRIAL LTDA.

      For this research, will be recruited up to 35 research participants who meet the inclusion /
      exclusion described in items 9.4 and 9.5 of the research protocol, to achieve a number of
      completion of 30 participants. Be recruited participants from both sexes, aged 18 and 65,
      which have dry skin on the feet and they are people with diabetes whose condition is
      stabilized.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin acceptability through the self perception of patients.</measure>
    <time_frame>2 months</time_frame>
    <description>Measure the skin acceptability through the self perception of patients with the daily use of the product adding in a questionnaire the product effectiveness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Instrumental Performance Measures</measure>
    <time_frame>2 months</time_frame>
    <description>Instrumental measurements will be carried out through the Skin-Thermometer ST equipment 500 - Courage + Khazaka in the feet of participants with the aid of a dermatologist.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Laboratoires Mercurochrome Reparador</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A group of patients will be treated with a new restorative skin cream consists of hyperoxygenation essential fatty acids (60% linoleic acid) which does not contain preservatives (parabens) or known allergens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laboratoires Mercurochrome Reparador</intervention_name>
    <description>Developed for the treatment of damaged or fragile skin.</description>
    <arm_group_label>Laboratoires Mercurochrome Reparador</arm_group_label>
    <other_name>Urgo Repair</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants healthy research;

          -  Intact skin on feet - grade 0 in the Wagner scale;

          -  Agreement to adhere to the procedures and requirements of the study and attend to the
             Office (s) day (s) and time (s) set (s) for evaluations;

          -  Ability to consent to participate in writing;

          -  Age 18 to 65 years;

          -  Research Participants of both sexes - including at least three men;

          -  Introducing dry skin on feet - dermatological proof.

          -  Participants with diabetes whose condition is stabilized

        Exclusion Criteria:

          -  Pregnancy and lactation; skin pathology in the product application area;

          -  immune impairment;

          -  Current use of these medications for topical or systemic use: corticoid,
             immunosuppressants, antihistamines, anticoagulants or birth;

          -  Skin diseases: psoriasis, vitiligo, atopic dermatitis;

          -  History of reaction to the category of the product tested;

          -  Other diseases or medications that may interfere directly in the study or to endanger
             the health of the research participant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Tepas, Graduated</last_name>
    <role>Study Director</role>
    <affiliation>Urgo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nesser C Oliveira, Graduated</last_name>
    <phone>551230021316</phone>
    <email>n.oliveira@br.urgo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sheila M Vieira, Graduated</last_name>
    <phone>551232021316</phone>
    <email>s.vieira@br.urgo.com</email>
  </overall_contact_backup>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2016</study_first_submitted>
  <study_first_submitted_qc>February 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2016</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Skin acceptability</keyword>
  <keyword>Clinical Research</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

